The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Acute Cerebral Infarction
Status:
Suspended
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purposes of the study is to determine the safety and efficacy of treating acute ischemic
stroke patients with human umbilical cord mesenchymal stem cells (hUC-MSC).